[Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality]

Med Clin (Barc). 2015 Sep 7;145(5):224-6. doi: 10.1016/j.medcli.2014.07.001. Epub 2014 Sep 2.

[Article in Spanish]

Authors

Cristina Calderón-Cabrera¹, Jose F Falantes², Ricardo Bernal¹, Jose A Pérez-Simón¹

Affiliations

¹ Servicio de Hematología. Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, España.
² Servicio de Hematología. Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, España. Electronic address: josef.falantes.sspa@juntadeandalucia.es.

PMID: 25190583
DOI: 10.1016/j.medcli.2014.07.001

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chromosome Inversion*
Chromosomes, Human, Pair 3 / genetics
Chromosomes, Human, Pair 3 / ultrastructure*
Combined Modality Therapy
Disease Progression
Female
Graft vs Host Disease / mortality
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / therapy
Male
Middle Aged
Myelodysplastic Syndromes / drug therapy
Myelodysplastic Syndromes / genetics*
Myelodysplastic Syndromes / therapy
Prognosis
Translocation, Genetic*
Treatment Outcome